U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H34N4O5
Molecular Weight 494.5827
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RETOSIBAN

SMILES

[H][C@]1([C@@H](C)CC)N([C@@H](C(=O)N2CCOCC2)C3=COC(C)=N3)C(=O)[C@H](NC1=O)C4CC5=C(C4)C=CC=C5

InChI

InChIKey=PLVGDGRBPMVYPB-FDUHJNRSSA-N
InChI=1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1

HIDE SMILES / InChI

Molecular Formula C27H34N4O5
Molecular Weight 494.5827
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 4 / 4
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Fri Dec 15 15:25:47 UTC 2023
Edited
by admin
on Fri Dec 15 15:25:47 UTC 2023
Record UNII
GIE06H28OX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RETOSIBAN
INN   USAN  
INN   USAN  
Official Name English
GSK-221149
Code English
MORPHOLINE, 4-((2R)-2-((3R,6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-6-((1S)-1-METHYLPROPYL)-2,5-DIOXO-1-PIPERAZINYL)-2-(2-METHYL-4-OXAZOLYL)ACETYL)-
Systematic Name English
GSK221149
Code English
retosiban [INN]
Common Name English
(3R,6R)-6-[(2S)-Butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]piperazine-2,5-dione
Systematic Name English
GSK221149A
Code English
RETOSIBAN [USAN]
Common Name English
GSK-221149A
Code English
Classification Tree Code System Code
NCI_THESAURUS C98292
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
Code System Code Type Description
PUBCHEM
11340891
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
EPA CompTox
DTXSID00231559
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
EVMPD
SUB181222
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
FDA UNII
GIE06H28OX
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
WIKIPEDIA
Retosiban
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
USAN
TT-30
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
CAS
820957-38-8
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
ChEMBL
CHEMBL429736
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
SMS_ID
100000166887
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
DRUG BANK
DB11818
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
INN
8924
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
NCI_THESAURUS
C76681
Created by admin on Fri Dec 15 15:25:47 UTC 2023 , Edited by admin on Fri Dec 15 15:25:47 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY